Biospecimens available to advance to research on heart disease and diabetes
July 17, 2014
The Fairbanks Institute for Healthy Communities and Indiana Clinical and Translational Science Institute and are calling for applications from IU researchers to access biospecimens to advance research on coronary artery disease and type 2 diabetes.
The Fairbanks Institute is a non-profit organization that operates INbank, which contains biological samples are linked with longitudinal clinical and disease-specific health records information from the Indiana Network for Patient Care, a state-wide electronic clinical data repository.
The INPC link enables the Fairbanks Institute to connect bio-specimens drawn at a point in time or over time with active patient medical record information, creating a longitudinal view of the subjects disease progression, interventions and outcomes. Fairbanks Institutes collection consists of samples from two disease based study collections which are the coronary artery disease collection and the type 2 diabetes collection.
Applications are due 5 p.m. Friday, Aug. 15. Samples will be provided free of charge to qualified investigators. This application is designed to promote research studies using the Fairbanks Institute's samples. Only bio-specimen will be made available. Requests for other resources are not permissible.
Submissions must include a current maximum four-page NIH biosketch. For complete application guidelines and materials, visit the Indiana CTSI's grants portal and enter your institutional username and password. Applications instructions are located under "Fairbanks Institute: Biological Samples with Longitudinal EHR Data for Research - 2014.08."